D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
926
Somnigroup International
SGI
$13.7B
| $15.5M | 0.02% |
641,500
-528,794
| -45% | -$13.7M |
|
927
SiteOne Landscape Supply
SITE
$4.12B
| $15.4M | 0.02% |
148,295
+291
| +0.2% | +$36.4K |
|
928
PUT
Best Buy
BBY
$18.2B
| $15.4M | 0.02% |
243,100
+12,700
| +6% | +$941K |
|
929
AbbVie
ABBV
$443B
| $15.4M | 0.02% |
114,583
+12,772
| +13% | +$1.83M |
|
|
BHVN
930
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $15.4M | 0.02% |
101,674
-127,073
| -56% | -$18.8M |
|
|
SNBR
931
DELISTED
Sleep Number
SNBR
| $15.4M | 0.02% |
454,549
+42,890
| +10% | +$1.72M |
|
932
FMC
FMC
$1.34B
| $15.3M | 0.02% |
+144,956
| New | +$15.6M |
|
933
Dollar General
DG
$28B
| $15.3M | 0.02% |
63,739
+62,239
| +4,149% | +$15.4M |
|
934
CALL
Affirm
AFRM
$23.9B
| $15.3M | 0.02% |
814,000
+394,000
| +94% | +$10.3M |
|
935
Xcel Energy
XEL
$48.8B
| $15.3M | 0.02% |
238,525
+213,679
| +860% | +$15.6M |
|
936
Brown-Forman Class B
BF.B
$13.2B
| $15.2M | 0.02% |
228,814
-43,918
| -16% | -$3.19M |
|
937
Warrior Met Coal
HCC
$4.19B
| $15.2M | 0.02% |
533,770
-25,515
| -5% | -$785K |
|
|
FYBR
938
DELISTED
Frontier Communications
FYBR
| $15.1M | 0.02% |
645,407
-279,057
| -30% | -$7.11M |
|
|
Y
939
PUT
DELISTED
Alleghany Corp
Y
| $15.1M | 0.02% |
18,000
-10,000
| -36% | -$8.39M |
|
940
PUT
Wynn Resorts
WYNN
$10.3B
| $15.1M | 0.02% |
238,900
-71,100
| -23% | -$4.43M |
|
|
TWOU
941
DELISTED
2U Inc
TWOU
| $15.1M | 0.02% |
80,284
+16,924
| +27% | +$4.41M |
|
942
Peabody Energy
BTU
$2.6B
| $15M | 0.02% |
603,952
+536,453
| +795% | +$12M |
|
943
PUT
The Mosaic Company
MOS
$7.03B
| $14.9M | 0.02% |
309,100
-462,000
| -60% | -$23.9M |
|
|
BYNO
944
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
| $14.9M | 0.02% |
1,485,000
+742,500
| +100% | +$7.41M |
|
945
CareDx
CDNA
$2.26B
| $14.9M | 0.02% |
875,230
+389,618
| +80% | +$8.36M |
|
946
BioNTech
BNTX
$22.9B
| $14.9M | 0.02% |
110,315
-234,278
| -68% | -$35.8M |
|
|
PINC
947
DELISTED
Premier
PINC
| $14.8M | 0.02% |
437,550
-85,744
| -16% | -$3.13M |
|
948
CALL
Cigna
CI
$73.8B
| $14.8M | 0.02% |
53,500
-11,600
| -18% | -$3.26M |
|
949
Goldman Sachs
GS
$300B
| $14.8M | 0.02% |
50,639
-116,872
| -70% | -$37.9M |
|
950
Neurocrine Biosciences
NBIX
$16.8B
| $14.8M | 0.02% |
139,262
-80,475
| -37% | -$8.17M |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.